Audrey Larnaudie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Audrey Larnaudie has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Pierre Blanchard
Department of Radiotherapy, Institut Gustave-Roussy, Villejuif, France
3 shared publicationsYoann Pointreau
Department of Radiotherapy, Institut interrégional de cancérologie, centre Jean-Bernard, centre de cancérologie de la Sarthe, Le Mans, France; Groupe d'oncologie radiothérapie tête et cou (Gortec; head and neck oncology and radiotherapy group), Tours, France
3 shared publications- Jennifer Le Guevelou
Department of Radiation Oncology CHRU Tours Tours France
2 shared publications - Juliette Thariat
Department of Radiation Oncology, Centre François Baclesse, Caen, France
2 shared publications Sébastien Thureau
2 shared publications- Adrien Laville
INSERM UMR 1030, Gustave Roussy Cancer Campus, 94805 Villejuif, France
1 shared publication
Latest Publications
- Open Access
- 30 July 2026
- Published by Elsevier in SSRN Electronic Journal
Evaluation of the nutritional and digestive impact of irradiation in nasopharyngeal cancers: the French multicenter retrospective DRAKAR study
ObjectiveRadiotherapy for nasopharyngeal cancers is associated with frequent digestive and nutritional toxicities, weight loss (WL), and malnutrition, criteria of poor tolerance and poor prognosis. The primary objective of DRAKAR is to evaluate of benefit of anticipated EN during radiotherapy for nasopharyngeal cancer, in a non-endemically affected French population.Materials and methodsDRAKAR is a retrospective, multicenter study conducted in five French centers. Patients received radiotherapy with curative intent, with or without concurrent chemotherapy, for primary nasopharyngeal cancer between 2015 and 2024. The primary endpoint was WL according to nutritional support modality at the end of radiotherapy. Secondary endpoints included rates of moderate and severe malnutrition (5% or 10% WL in one month for moderate and severe malnutrition), grade ≥ 3 toxicities, dosimetric parameters (volumes, particles), use and duration of enteral nutrition and parenteral nutrition, prolonged radiotherapy due to treatment interruption, hospitalizations, and overall survival.ResultsA total of 124 patients were analyzed (59.7% UCNT, 40.3% squamous cell carcinoma). At one month, 35.5% presented with malnutrition. Mean WL was 7.46% at the end of radiotherapy and 9.11% at three months. Enteral nutrition was used in 55.6% of patients, including 16.1% prophylactically. Prophylactic enteral nutrition allowed stabilization of WL after treatment. Grade ≥ 3 mucositis and radiation-induced nausea and vomiting occurred in 31.5% and 14.5% of patients, respectively. No association was found between toxicities and clinical, dosimetric, or therapeutic characteristics.ConclusionIn patients treated for nasopharyngeal cancer, prophylactic enteral nutrition was associated with lower WL at the end of radiotherapy. Although it had neither positive impact on hospitalization rates nor on overall survival, these results support prophylactic nutritional support during radiotherapy of nasopharyngeal cancers, mainly for post-treatment WL.
- 30 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessEvaluation of the nutritional and digestive impact of irradiation in nasopharyngeal cancers: the French multicenter retrospective DRAKAR study
ObjectiveRadiotherapy for nasopharyngeal cancers is associated with frequent digestive and nutritional toxicities, weight loss (WL), and malnutrition, criteria of poor tolerance and poor prognosis. The primary objective of DRAKAR is to evaluate of benefit of anticipated EN during radiotherapy for nasopharyngeal cancer, in a non-endemically affected French population.Materials and methodsDRAKAR is a retrospective, multicenter study conducted in five French centers. Patients received radiotherapy with curative intent, with or without concurrent chemotherapy, for primary nasopharyngeal cancer between 2015 and 2024. The primary endpoint was WL according to nutritional support modality at the end of radiotherapy. Secondary endpoints included rates of moderate and severe malnutrition (5% or 10% WL in one month for moderate and severe malnutrition), grade ≥ 3 toxicities, dosimetric parameters (volumes, particles), use and duration of enteral nutrition and parenteral nutrition, prolonged radiotherapy due to treatment interruption, hospitalizations, and overall survival.ResultsA total of 124 patients were analyzed (59.7% UCNT, 40.3% squamous cell carcinoma). At one month, 35.5% presented with malnutrition. Mean WL was 7.46% at the end of radiotherapy and 9.11% at three months. Enteral nutrition was used in 55.6% of patients, including 16.1% prophylactically. Prophylactic enteral nutrition allowed stabilization of WL after treatment. Grade ≥ 3 mucositis and radiation-induced nausea and vomiting occurred in 31.5% and 14.5% of patients, respectively. No association was found between toxicities and clinical, dosimetric, or therapeutic characteristics.ConclusionIn patients treated for nasopharyngeal cancer, prophylactic enteral nutrition was associated with lower WL at the end of radiotherapy. Although it had neither positive impact on hospitalization rates nor on overall survival, these results support prophylactic nutritional support during radiotherapy of nasopharyngeal cancers, mainly for post-treatment WL.
- 26 March 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 219, 111479
Discontinuation of the double-blind, placebo-controlled randomized, phase III GORTEC 2022–01 trial of radiotherapy-cetuximab and xevinapant in patients with locally advanced squamous cell carcinoma of the head and neck, unfit for cisplatin
- 26 March 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 219, 111479
Discontinuation of the double-blind, placebo-controlled randomized, phase III GORTEC 2022–01 trial of radiotherapy-cetuximab and xevinapant in patients with locally advanced squamous cell carcinoma of the head and neck, unfit for cisplatin
- 21 November 2025
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 29 (7-8) , 104728
Radiotherapy of sinonasal cancers: 2025 update
- 21 November 2025
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 29 (7-8) , 104728
Radiotherapy of sinonasal cancers: 2025 update
- Open Access
- 14 April 2025
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 53, 100962
Stereotactic body radiotherapy for early glottic cancers: Is this “The Way”?
- 14 April 2025
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 53, 100962
Open AccessStereotactic body radiotherapy for early glottic cancers: Is this “The Way”?
- Open Access
Excitement and Concerns of Young Radiation Oncologists over Automatic Segmentation: A French Perspective
Introduction: Segmentation of organs at risk (OARs) and target volumes need time and precision but are highly repetitive tasks. Radiation oncology has known tremendous technological advances in recent years, the latest being brought by artificial intelligence (AI). Despite the advantages brought by AI for segmentation, some concerns were raised by academics regarding the impact on young radiation oncologists’ training. A survey was thus conducted on young french radiation oncologists (ROs) by the SFjRO (Société Française des jeunes Radiothérapeutes Oncologues). Methodology: The SFjRO organizes regular webinars focusing on anatomical localization, discussing either segmentation or dosimetry. Completion of the survey was mandatory for registration to a dosimetry webinar dedicated to head and neck (H & N) cancers. The survey was generated in accordance with the CHERRIES guidelines. Quantitative data (e.g., time savings and correction needs) were not measured but determined among the propositions. Results: 117 young ROs from 35 different and mostly academic centers participated. Most centers were either already equipped with such solutions or planning to be equipped in the next two years. AI segmentation software was mostly useful for H & N cases. While for the definition of OARs, participants experienced a significant time gain using AI-proposed delineations, with almost 35% of the participants saving between 50–100% of the segmentation time, time gained for target volumes was significantly lower, with only 8.6% experiencing a 50–100% gain. Contours still needed to be thoroughly checked, especially target volumes for some, and edited. The majority of participants suggested that these tools should be integrated into the training so that future radiation oncologists do not neglect the importance of radioanatomy. Fully aware of this risk, up to one-third of them even suggested that AI tools should be reserved for senior physicians only. Conclusions: We believe this survey on automatic segmentation to be the first to focus on the perception of young radiation oncologists. Software developers should focus on enhancing the quality of proposed segmentations, while young radiation oncologists should become more acquainted with these tools.
Open AccessExcitement and Concerns of Young Radiation Oncologists over Automatic Segmentation: A French Perspective
Introduction: Segmentation of organs at risk (OARs) and target volumes need time and precision but are highly repetitive tasks. Radiation oncology has known tremendous technological advances in recent years, the latest being brought by artificial intelligence (AI). Despite the advantages brought by AI for segmentation, some concerns were raised by academics regarding the impact on young radiation oncologists’ training. A survey was thus conducted on young french radiation oncologists (ROs) by the SFjRO (Société Française des jeunes Radiothérapeutes Oncologues). Methodology: The SFjRO organizes regular webinars focusing on anatomical localization, discussing either segmentation or dosimetry. Completion of the survey was mandatory for registration to a dosimetry webinar dedicated to head and neck (H & N) cancers. The survey was generated in accordance with the CHERRIES guidelines. Quantitative data (e.g., time savings and correction needs) were not measured but determined among the propositions. Results: 117 young ROs from 35 different and mostly academic centers participated. Most centers were either already equipped with such solutions or planning to be equipped in the next two years. AI segmentation software was mostly useful for H & N cases. While for the definition of OARs, participants experienced a significant time gain using AI-proposed delineations, with almost 35% of the participants saving between 50–100% of the segmentation time, time gained for target volumes was significantly lower, with only 8.6% experiencing a 50–100% gain. Contours still needed to be thoroughly checked, especially target volumes for some, and edited. The majority of participants suggested that these tools should be integrated into the training so that future radiation oncologists do not neglect the importance of radioanatomy. Fully aware of this risk, up to one-third of them even suggested that AI tools should be reserved for senior physicians only. Conclusions: We believe this survey on automatic segmentation to be the first to focus on the perception of young radiation oncologists. Software developers should focus on enhancing the quality of proposed segmentations, while young radiation oncologists should become more acquainted with these tools.